Clinical Results In 1004 Patients with Localized Prostate Cancer Treated with External Beam Radiotherapy, High Dose-rate 192-iridium Brachytherapy Boost, and Neo-adjuvant Hormonal Therapy

To report the clinical outcome in 1004 patients with localized prostate cancer treated with external beam radiotherapy, high dose-rate 192-Iridium brachytherapy boost, and neo-adjuvant hormonal therapy, treated at a single institution. In 1998, we instituted a program for the treatment of localized prostate cancer with neoadjuvant hormonal therapy, external beam radiotherapy (2 Gy per fraction, 25 fractions), a boost of HDR brachytherapy (10 Gy...